Evidence map›Paper›PMID 38001838›Full record

ArticleAntioxidants (Basel, Switzerland)2023

The Role of Ozone as an Nrf2-Keap1-ARE Activator in the Anti-Microbial Activity and Immunity Modulation of Infected Wounds.

Marianno Franzini, Luigi Valdenassi, Sergio Pandolfi, Umberto Tirelli, Giovanni Ricevuti, Salvatore Chirumbolo

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Bone reports · 2026
    Article
  3. Review
  4. Review
  5. Ozone in Botulinum Toxin-Induced Ptosis: Some Comments.Journal of cosmetic dermatology · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Marianno FranziniItalian Scientific Society of Oxygen-Ozone Therapy (SIOOT), 24020 Bergamo, Italy.
Luigi ValdenassiItalian Scientific Society of Oxygen-Ozone Therapy (SIOOT), 24020 Bergamo, Italy.
Sergio PandolfiItalian Scientific Society of Oxygen-Ozone Therapy (SIOOT), 24020 Bergamo, Italy.
Umberto TirelliTirelli Medical Group, 33170 Pordenone, Italy.
Giovanni RicevutiDepartment of Drug Science, University of Pavia, 27100 Pavia, Italy.ORCID 0000-0003-3422-2747
Salvatore ChirumboloDepartment of Engineering for Innovation Medicine, University of Verona, 37125 Verona, Italy.ORCID 0000-0003-1789-8307
University of Pavia · ITUniversity of Verona · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ozone is an allotrope of oxygen, widely known to exert an anti-oxidant potential. The ability of low, controlled and standardized doses of ozone in the ozone adjunct treatment of bacterial infections, which occur in wounds, is engaging clinical research to deepen the role of ozone in eradicating even multidrug-resistant bacteria. Ozone activates the nuclear factor erythroid 2-related factor 2 (Nrf2), and this activation triggers a complex cascade of events, which ultimately leads to macrophage training and an improvement in their ability to operate a clearance of bacteria in the patient's anatomical districts. In this review, we try to elucidate the recent evidence about the mechanisms with which ozone can actually remove bacteria and even multi-drug-resistant (MDR) bacteria, accounting on its complex ability in modulating immunity.

Indexed as

immunitymacrophagemacrophage trainingNrf2ozonetolerance

Identifiers

PMID38001838
PMCPMC10669564
OpenAlexW4388532704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.